Navigation Links
Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
Date:8/4/2009

CRANBURY, N.J., Aug. 4 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its U.S. Patent Application Number 11/694,260, titled "Cyclic Natriuretic Peptide Constructs." Allowed claims cover a family of cyclic compounds that bind to natriuretic peptide receptor A (NPRA), including PL-3994, Palatin's lead heart failure drug candidate. Palatin expects the patent will issue in the second half of 2009; the patent's 20-year term would expire in 2027.

"We are extremely pleased to be getting this patent coverage," said Palatin President and CEO Carl Spana. "PL-3994 and related compounds are first-in-class peptide mimetics with extended half-lives and favorable pharmacokinetic properties. These are the only drugs we are aware of that bind to NPRA and are suitable for subcutaneous administration, with the possibility of once-daily administration."

PL-3994 and the related family of cyclic compounds were discovered entirely in-house and are owned by Palatin. In addition to the allowed U.S. patent application, Palatin has applications pending in selected countries outside the United States and additional U.S. applications covering related compounds.

About PL-3994

Palatin has completed two clinical trials with PL-3994, a Phase 1 trial in healthy volunteers and a Phase 2a trial in patients with controlled hypertension. PL-3994 produced dose-related decreases in blood pressure, increases in plasma cGMP (cyclic guanosine monophosphate), a natural messenger nucleotide, and increases in urine volume and sodium excretion. There were no serious or severe adverse events.

PL-3994 incorporates a novel and proprietary amino acid mimetic developed by scien
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Palatin Technologies Listing Compliance Plan Accepted by NYSE Alternext US
2. Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009
3. Palatin Technologies Receives Notification Letter from NYSE Alternext US
4. Palatin Technologies to Report Fiscal Year 2009 First Quarter Results; Conference Call and Webcast on November 17, 2008
5. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
6. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
7. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
9. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
10. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
11. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...a.,Nov.25/PRNewswire/--Formanybusinesses,2009hasbe...estandfastestgrowingnetworkofexpertphysiciansspeci...alhormones has grownthenumberof physiciansinitsn...ndisinprogresstoaddmorephysician-ownedcenters,incl...hepastyear ,BodyLogicMDhasopened13newbioidenticalh...
(Date:11/25/2009)...swire-FirstCall/--ArdeaBiosciences,Inc.(Nasdaq: RD...entandchiefexecutiveofficer,willpresentatthePiperJ...tiondetailsareasfollows:,PiperJaffray21stAnnualHe...e:2:00p.m.EasternTime,Location:TheNewYorkPalaceHot...-ir.net/ireye/,target=,_blank,title=,http://www.c...
(Date:11/24/2009)... New York investment bank KTA Capital,s client Neu...$6.7 mil convertible note private placement with a...t was arranged by KTA Capital as Neuren,s exclusiv... New York (PRWEB) November 23, 2009 -- The ...LLC ("KTA Capital") has announced that i...
(Date:11/24/2009)...swire-FirstCall/--Sigma-AldrichCorporation(Nasdaq:...uesday,December1stat1:45PMGMTinLondon,7:45AMUS/CST...ertheInternetavailableat http://inve s tor.sig ...contoaccessthisfile. ,, AboutSigma-Aldrich: ...ycompany.Itschemicalandbiochemicalproductsandkitsa...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...never cease to be amazed by the games that some co...ding quest to goose up revenues and shore up profi...mers rather than pleasing them. Lately, things hav...he good old days of those intrusive evening telema...sance of spam although I admit it is a huge pain-...
...Harry Whelan Harry Whelan has become the first ...pointed to the National Defense University in Wash...nd director of the college,s hyperbaric medicine u... for Technology and National Security Policy . One...ng the appointment, he will be spending approximat...
... Milken Institute predicts moderate Wisconsin biop... Fiserv network Third Wave appoints regulatory ... Wisconsin biopharmaceutical growth ,Wisconsin is...but will generate few jobs in the field, according...tute, an economic think tank, and sponsored by the...
Other Biology Technology:Show customers leadership, not gamesmanship 2Show customers leadership, not gamesmanship 3Medical College of Wisconsin researcher gets national defense appointment 2Tech Digest: whats moving in the Midwest 2
(Date:11/23/2009)...ence that the "synergistic" effect of early-life e...and indoor endotoxin causes more harm to developin... Environmental health scientists at the Universit...n that children exposed to both high levels of tra... early life are six times more likely to experienc...
(Date:11/23/2009)...Society says that western lowland gorillas living ...he "mother lode" of more than 125,000 gorillas dis...ned by growing humans activity in the region. , ...ts adjacent to the southwest border of Lac Tl Comm...high densities of the great apes still exist in th...
(Date:11/23/2009)...able for the H1N1 virus has been sent to vaccinate...tion marks the first time vaccine has been sent to...Iowa State University,s Hank Harris, professor of ...and has been shipping preventive doses to swine pr...eeks., The latest vaccines were shipped to a swi...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Risk Evaluation and Mitigation Strategy Experts Interpret New FDA REMS Guidance 5155 1Sanofi Pasteur Announces Results of U S Clinical Trials in Adults Following One Dose of Influenza A 28H1N1 29 Vaccine 5153 1Sanofi Pasteur Announces Results of U S Clinical Trials in Adults Following One Dose of Influenza A 28H1N1 29 Vaccine 5153 2Sanofi Pasteur Announces Results of U S Clinical Trials in Adults Following One Dose of Influenza A 28H1N1 29 Vaccine 5153 3Sanofi Pasteur Announces Results of U S Clinical Trials in Adults Following One Dose of Influenza A 28H1N1 29 Vaccine 5153 4Sanofi Pasteur Announces Results of U S Clinical Trials in Adults Following One Dose of Influenza A 28H1N1 29 Vaccine 5153 5Sanofi Pasteur Announces Results of U S Clinical Trials in Adults Following One Dose of Influenza A 28H1N1 29 Vaccine 5153 6Safe Drug Drop Off Sheriff Baca LA County Communities and Narconon Join Together to Get Drugs Out of the Medicine Cabinet 5151 1Safe Drug Drop Off Sheriff Baca LA County Communities and Narconon Join Together to Get Drugs Out of the Medicine Cabinet 5151 2
... cause human blood and plasma to clota process tha...the course of vertebrate evolution, according to n... Institute of Allergy and Infectious Diseases, and... published online Nov. 2 in Nature Chemical Biolo...rstanding of coagulation during bacterial infectio...
...ns interact in a previously unknown molecular mech...tudies looking for the causes of defective organs ... according to researchers at Cincinnati Children,s...in the Oct. 15 Genes & Development , the research...nd behavior in the forming organs of embryos. , "...
...shells to bones, the skeletons of organisms contai...sium. Because the levels of these elements provide...ble effort has focused on understanding how to rel...in which an organism lived. , In the October 31 ... Ph.D. candidate in geoscience, and Patricia Dove,...
Other Biology News:Nature study demonstrates that bacterial clotting depends on clustering 2New regulatory mechanism discovered for cell identify and behavior in forming organs 2New regulatory mechanism discovered for cell identify and behavior in forming organs 3Bare bones of crystal growth: Biomolecules enhance metal contents in calcite 2
FliTrx Panning Kit from Invitrogen
...ludes: Sufficient library for 10 separate biopanni...equences, -28 gIII Sequencing Primer (100 pmol), f...er (100 pmol), for automated DNA sequencing, Host ...n) and Elutant (Biotin), Detailed protocols for su...
...ntigen and antibody-based immunoaffinity matrices,...ny times without compromising antigen-antibody rea...gents has precluded the application of these metho... Western Blot Mild Antibody Stripping Solution con...
...0 Series of positioning slides offers multiple dri... leadscrew, micrometer, and manual. With this seri...ective multi-axis systems. These slides also offer...solutions down to 10 nanometers, integrated home/ ...
Biology Products: